A clinical trial to study the effect of myoinositol based therapy in combination with metformin as compared to metformin alone in women with polycystic ovarian syndrome
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2021/03/032468
- Lead Sponsor
- Roshan Nazirudeen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Overweight or obese as defined by a BMI>=23
2. Diagnosed to have polycystic ovarian syndrome according to the Rotterdam criteria by presence of any two out of the following: oligo/anovulation, clinical and/or biochemical evidence of hyperandrogenism, polycystic ovaries by ultrasound.
3. Giving informed consent
1. Causes of secondary PCOS including hyperprolactinemia, hypothyroidism, Cushingâ??s syndrome, adrenal and ovarian androgen secreting tumors, patients on medications thought to cause PCOS like valproate.
2. Liver disease or renal impairment
3. Diabetes mellitus
4. Intake of any drugs for PCOS treatment in past 3months
5. Ovarian drilling or any ovarian surgical procedures in the past 6 months
6. Not consenting to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method